Literature DB >> 3534307

Immunology of pyelonephritis. VIII. E. coli causes granulocytic aggregation and renal ischemia.

M B Kaack, K J Dowling, G M Patterson, J A Roberts.   

Abstract

We studied renal venous blood after renal infection for its concentrations of leukocytes, complement and renin. In addition, we evaluated this blood for granulocytic aggregation and chemiluminescence of granulocytes. We found that very rapid activation of serum complement occurred with associated granulocytic aggregation and evident vascular occlusion and ischemia since renin rose rapidly. It appears that this early sequence of events will cause renal damage by ischemic change, as well as that known to occur from the inflammatory reaction.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3534307     DOI: 10.1016/s0022-5347(17)45235-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

Review 1.  Urinary tract infections in children.

Authors:  Sherry Sedberry-Ross; Hans G Pohl
Journal:  Curr Urol Rep       Date:  2008-03       Impact factor: 3.092

2.  Effect of anticoagulant and platelet inhibition on the risk of bacteremia among patients with acute pyelonephritis: a retrospective cohort study.

Authors:  Svava E Steiner; Gustaf Edgren; Keira Melican; Agneta Richter-Dahlfors; Annelie Brauner
Journal:  BMC Infect Dis       Date:  2022-05-31       Impact factor: 3.667

Review 3.  The small scarred kidney in childhood.

Authors:  R A Risdon
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

4.  ICAM-1 expression is upregulated in reflux nephropathy.

Authors:  Kei Unemoto; Boris Chertin; Hideki Shima; Xun Bi; Masato Sakai; Prem Puri
Journal:  Pediatr Surg Int       Date:  2003-05-21       Impact factor: 1.827

5.  Tc-99m dimercaptosuccinic acid(DMSA) renal scintigraphy in patients with acute pyelonephritis.

Authors:  K W Lee; K T Bin; M S Jeong; M H Shong; Y T Shin; H K Ro
Journal:  Korean J Intern Med       Date:  1995-01       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.